NCT02647307View on ClinicalTrials.gov

Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Healthy
Interventions
DRUG

DS-1040b

Single 12-hour intravenous infusion of DS-1040b (20 mg)

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
collaborator

Hammersmith Medicines Research

OTHER

lead

Daiichi Sankyo

INDUSTRY

NCT02647307 - Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b | Biotech Hunter | Biotech Hunter